---
title: "Galera Therapeutics (GRTX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GRTX.US/norm.md"
symbol: "GRTX.US"
name: "Galera Therapeutics"
parent: "https://longbridge.com/en/quote/GRTX.US.md"
datetime: "2026-05-20T10:35:21.773Z"
locales:
  - [en](https://longbridge.com/en/quote/GRTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GRTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GRTX.US/norm.md)
---

# Galera Therapeutics (GRTX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0252 | 0.6861 | -0.0141 | -0.0109 | -0.0162 |
| ROE | -422.97% | -372.21% | 3.74% | 2.91% | 4.31% |
| Revenue | - | - | - | - | - |
| Net income | -2.49M | 67.58M | -1.39M | -1.07M | -1.59M |
| Operating income | -1.66M | -1.51M | -1.44M | -1.14M | -1.96M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 6.16M | 7.20M | 5.00M | 6.05M | 7.66M |
| Leverage | 1.23 | 1.10 | -0.0341 | -0.0416 | -0.0531 |
| BVPS | 0.0096 | 0.0527 | -1.98 | -1.96 | -1.95 |
| Turnover | - | - | - | - | - |
| Cash & STI | 5.50M | 6.38M | 4.47M | 5.23M | 6.69M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -5.50M | -6.38M | 146.58M | 145.82M | 144.36M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -875000.00 | -1.60M | -757000.00 | -1.46M | -2.24M |
| Investing CF | - | 3.50M | - | - | - |
| Financing CF | - | 0.0000 | 0.0000 | 0.0000 | 635000.00 |
| Free CF | -381375.00 | -1.10M | -266500.00 | -1.09M | -942875.00 |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |